Charcot-Marie-Tooth-1A and sciatic nerve crush rat models: insights from proteomics.

Area of Science:

• Neuroscience
• Proteomics
• Biochemistry

Background:

• Peripheral neuropathies, including Charcot-Marie-Tooth-1A disease and sciatic nerve crush, affect sensorimotor and histological functions.
• Understanding protein signatures in disease is crucial for developing pharmacological targets.
• Charcot-Marie-Tooth-1A rats exhibit more severe motor impairments in hind limbs.

Purpose of the Study:

• To compare the protein expression profiles in sciatic nerves of Charcot-Marie-Tooth-1A rats and rats subjected to sciatic nerve crush injury.
• To identify differentially expressed proteins and understand their roles in the pathophysiology of these peripheral neuropathies.
• To explore potential common and distinct molecular mechanisms underlying genetic and traumatic neuropathies.

Main Methods:

• Proteomic analysis using sequential window acquisition of all theoretical fragment ion spectra (SWATH-LC-MS/MS) on sciatic nerve samples.
• Comparison of protein expression between Charcot-Marie-Tooth-1A rats and wild-type controls (n=445 identified proteins, 153 significant).
• Analysis of protein expression in sciatic nerve crush injury model compared to uninjured controls (n=459 identified proteins, 92 significant).

Main Results:

• In Charcot-Marie-Tooth-1A rats, 153 proteins were differentially expressed, mostly upregulated, suggesting compensatory mechanisms for redox balance, protein folding, myelination, and axonogenesis.
• Oxidative stress response was a significant feature in Charcot-Marie-Tooth-1A.
• In sciatic nerve crush, 92 proteins were differentially expressed, mostly downregulated, with key roles in neurogenesis, axon injury response, and oxidative stress, indicating imperfect repair.

Conclusions:

• Peripheral neuropathies, regardless of genetic or traumatic origin, share common pathological pathways.
• Charcot-Marie-Tooth-1A involves complex compensatory mechanisms that are ultimately insufficient.
• The study provides insights into disease mechanisms and potential therapeutic targets for peripheral neuropathies.